Sangamo BioSciences | SGMO - SCHULD





SCHULD Veränderung Datum
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 54.59B 1.62B 2025-09
Bayer EUR 39.39B 1.31B 2025-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Grifols EUR 9.23B 626.05M 2024-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
J&J USD 45.8B 4.97B 2025-09
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Omeros USD 442.16M 199K 2023-09
Pfizer USD 60.85B 78M 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09